HCV Regimen: No Interferon, No Ribavirin, No Problem (CME/CE)

WASHINGTON (MedPage Today) -- Patients who failed to respond to standard treatment for hepatitis C virus infection achieved greater than 80% sustained virologic response with a regimen that eschewed both interferon and ribavirin, researchers reported.
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news